Diabetes: Type 1

Description

Alternative Names

Monitoring Tests

Glucose (Blood Sugar) Levels

Both hypoglycemia and hyperglycemia are of concern for patients who are receiving insulin. It is important, therefore, to monitor blood glucose levels carefully. In general, patients with type 1 diabetes need to take readings four or more times a day. Patients should aim for the following measurements:

• Pre-meal glucose levels of between 80 and 120 mg/dL.
• Bedtime levels of between 100 and 140 mg/dL.

Different goals may be required for specific individuals, including pregnant women, very old and very young people, and those with accompanying serious medical conditions.

Finger-Prick Test. A typical blood sugar test includes the following:

• A drop of blood is obtained by pricking the finger.
• The blood is then applied to a chemically treated strip.
• Home monitors are generally used to provide results.

Home monitors are about 10% to 15% less accurate than laboratory monitors are and many do not meet the standards of the American Diabetes Association. Many experts believe, however, that most are accurate enough to indicate when blood sugar is too low.

To monitor the amount of glucose within the blood a person with diabetes should test their blood regularly. The procedure is quite simple and can often be done at home.

Some simple procedures may improve accuracy:

• Testing the meter once a month.
• Recalibrating it whenever a new packet of strips is used.
• Using fresh strips. Outdated strips may not provide accurate results.
• Keeping the meter clean.
• Periodically comparing the meter results with the results from a laboratory.

Less Invasive or Noninvasive Tests. A number of noninvasive or less painful tests are on the market or under investigation. The following are some examples:

• A battery-powered wristwatch-like device (GlucoWatch) measures glucose by sending tiny electric currents through the skin--a technique called reverse iontophoresis. It is painless and has a warning device when detecting high glucose levels. It takes three hours to warm up and the sensor pads need to be changed every day. About a quarter of the time, it differs significantly from actual fingerstick tests, however, so it should be used to supplement, not replace, blood tests. Nevertheless, in one study it was very effective in improving glucose control in children and was well tolerated. The device in the study also included an alarm that allowed detection of nighttime hypoglycemia. Refinements in the technique should improve accuracy.
• The continuous glucose monitoring system (Minimed) uses a needle-like sensor inserted under the skin, which is attached to a beeper-like computer device worn by the patient. Glucose is measured every five minutes, and the results are stored in the device. After five days, the patient removes the sensor and the physician obtains data from the device, which is then used to identify trends and insulin needs. It is does not replace fingerstick tests.
• Some monitors, such as Sof-Tact and FreeStyle, have been designed to obtain blood from areas of the skin that are less sensitive. Both appear to be less painful than standard methods.
• Investigative pain-free monitors include laser devices (Altea MicroPor), microneedles, and infrared devices.

Glycated Hemoglobin

Hemoglobin A1c (HbA1c), or glycated hemoglobin, is measured periodically to determine the average blood-sugar level over the life span of the red blood cell, which is about eight to 10 weeks. In general, measurements suggest the following:

• Normal HbA1c levels should be below 7%.
• Levels of 11% to 12% glycolated hemoglobin indicate poor control of carbohydrates. High levels are also markers for kidney trouble.

Home tests (DRx, Metrika A1c Now) are available for measuring HbA1c that may allow even better monitoring of glucose levels. Metrika A1c Now is now sold over the counter.

Urine Tests

Urine tests are useful for detecting the presence of ketones, which should always be performed during illness or stressful situations, when diabetes is likely to go out of control. The patient should also undergo yearly urine tests for microalbuminuria (small amounts of protein in the urine), a risk factor for future kidney disease.

Eye Examinations

For patients beginning intensive insulin therapy, experts recommend an eye examination when starting treatments and every three months thereafter up to a year.